nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RXRG—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0212	0.0599	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0199	0.0563	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0104	0.0294	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—HNF4A—colon cancer	0.00776	0.0219	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptors—HNF4A—colon cancer	0.0071	0.0201	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—HNF4A—colon cancer	0.00696	0.0197	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—HNF4A—colon cancer	0.00667	0.0189	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—HNF4A—colon cancer	0.00667	0.0189	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00613	0.0173	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00561	0.0159	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0055	0.0155	CbGpPWpGaD
Isotretinoin—RXRA—renal system—colon cancer	0.00544	0.12	CbGeAlD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00529	0.015	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00527	0.0149	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00527	0.0149	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00475	0.0134	CbGpPWpGaD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00457	0.0129	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00455	0.0129	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00418	0.0118	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00409	0.0116	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00393	0.0111	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00393	0.0111	CbGpPWpGaD
Isotretinoin—RARA—renal system—colon cancer	0.00375	0.0827	CbGeAlD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00368	0.0104	CbGpPWpGaD
Isotretinoin—RARB—vagina—colon cancer	0.00354	0.0781	CbGeAlD
Isotretinoin—RXRA—Nuclear Receptors—HNF4A—colon cancer	0.00348	0.00983	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—PPARG—colon cancer	0.00337	0.00952	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00333	0.00941	CbGpPWpGaD
Isotretinoin—RXRA—liver—colon cancer	0.00332	0.0733	CbGeAlD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.0033	0.00934	CbGpPWpGaD
Isotretinoin—RARG—digestive system—colon cancer	0.00327	0.0721	CbGeAlD
Isotretinoin—RXRB—vagina—colon cancer	0.00325	0.0717	CbGeAlD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00319	0.00902	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00317	0.00895	CbGpPWpGaD
Isotretinoin—RARA—lymphoid tissue—colon cancer	0.00311	0.0686	CbGeAlD
Isotretinoin—RXRG—Nuclear Receptors—PPARG—colon cancer	0.00308	0.00871	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—PPARG—colon cancer	0.00302	0.00854	CbGpPWpGaD
Isotretinoin—RARB—liver—colon cancer	0.00298	0.0659	CbGeAlD
Isotretinoin—RXRB—Nuclear Receptors—PPARG—colon cancer	0.0029	0.00819	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—PPARG—colon cancer	0.0029	0.00819	CbGpPWpGaD
Isotretinoin—RARG—vagina—colon cancer	0.00289	0.0637	CbGeAlD
Isotretinoin—RARA—bone marrow—colon cancer	0.00283	0.0625	CbGeAlD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00275	0.00777	CbGpPWpGaD
Isotretinoin—RXRB—liver—colon cancer	0.00274	0.0605	CbGeAlD
Isotretinoin—RARG—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00266	0.00753	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00266	0.00752	CbGpPWpGaD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.0026	0.00734	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—CDH1—colon cancer	0.00257	0.00725	CbGpPWpGaD
Isotretinoin—RXRA—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00249	0.00704	CbGpPWpGaD
Isotretinoin—RXRG—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00244	0.00688	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00244	0.00688	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—CDH1—colon cancer	0.00241	0.00682	CbGpPWpGaD
Isotretinoin—RARB—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00239	0.00675	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00239	0.00675	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00237	0.00671	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—PPARG—colon cancer	0.00234	0.00661	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00233	0.00658	CbGpPWpGaD
Isotretinoin—RXRB—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00229	0.00647	CbGpPWpGaD
Isotretinoin—RARA—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00229	0.00647	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00229	0.00647	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00229	0.00647	CbGpPWpGaD
Isotretinoin—RARA—liver—colon cancer	0.00229	0.0505	CbGeAlD
Isotretinoin—RARB—lymph node—colon cancer	0.00229	0.0505	CbGeAlD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00227	0.00642	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00223	0.00631	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00223	0.00631	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00218	0.00616	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00205	0.00578	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00191	0.00541	CbGpPWpGaD
Isotretinoin—RARG—lymph node—colon cancer	0.00187	0.0412	CbGeAlD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00183	0.00518	CbGpPWpGaD
Isotretinoin—RARA—lymph node—colon cancer	0.00176	0.0387	CbGeAlD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00166	0.0047	CbGpPWpGaD
Isotretinoin—RARG—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00161	0.00455	CbGpPWpGaD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—EP300—colon cancer	0.00155	0.00437	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00153	0.00432	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—PPARG—colon cancer	0.00151	0.00427	CbGpPWpGaD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—SRC—colon cancer	0.0015	0.00425	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—colon cancer	0.0015	0.00424	CbGpPWpGaD
Isotretinoin—RXRG—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00147	0.00416	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00147	0.00414	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—CCND1—colon cancer	0.00145	0.00411	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—EP300—colon cancer	0.00145	0.00411	CbGpPWpGaD
Isotretinoin—RARB—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00144	0.00408	CbGpPWpGaD
Isotretinoin—RXRA—REV-ERBA represses gene expression—EP300—colon cancer	0.00143	0.00403	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—SRC—colon cancer	0.00141	0.00399	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—colon cancer	0.00141	0.00399	CbGpPWpGaD
Isotretinoin—RXRB—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00138	0.00391	CbGpPWpGaD
Isotretinoin—RARA—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00138	0.00391	CbGpPWpGaD
Isotretinoin—RXRA—RORA activates circadian gene expression—EP300—colon cancer	0.00138	0.0039	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—PIK3CA—colon cancer	0.0013	0.00368	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—CDH1—colon cancer	0.00126	0.00355	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—colon cancer	0.00123	0.00346	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—colon cancer	0.00121	0.00341	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00119	0.00337	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00119	0.00337	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00119	0.00337	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00117	0.00331	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—MYC—colon cancer	0.00117	0.0033	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00116	0.00329	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—PPARG—colon cancer	0.00115	0.00326	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00114	0.00323	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00114	0.00321	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—colon cancer	0.00113	0.0032	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00113	0.00319	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00112	0.00318	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—PPARG—colon cancer	0.00108	0.00306	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00108	0.00306	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.00106	0.00301	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—HNF4A—colon cancer	0.00106	0.00299	CbGpPWpGaD
Isotretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.00101	0.00285	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.001	0.00283	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—HNF4A—colon cancer	0.000969	0.00274	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000956	0.0027	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—HNF4A—colon cancer	0.00095	0.00269	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—HNF4A—colon cancer	0.000911	0.00257	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—HNF4A—colon cancer	0.000911	0.00257	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000861	0.00243	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—colon cancer	0.000858	0.00243	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000825	0.00233	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—CTNNB1—colon cancer	0.000811	0.00229	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—CDKN1A—colon cancer	0.000792	0.00224	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000764	0.00216	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—CTNNB1—colon cancer	0.000762	0.00215	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—EP300—colon cancer	0.000757	0.00214	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—CDKN1A—colon cancer	0.000745	0.0021	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—SRC—colon cancer	0.000736	0.00208	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—colon cancer	0.000736	0.00208	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—EP300—colon cancer	0.000735	0.00208	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.000721	0.00204	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CA7—colon cancer	0.000693	0.00196	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TGFB1—colon cancer	0.000655	0.00185	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000653	0.00185	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—PPARG—colon cancer	0.000645	0.00182	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—colon cancer	0.000638	0.0018	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.000632	0.00178	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000626	0.00177	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TGFB1—colon cancer	0.000616	0.00174	CbGpPWpGaD
Isotretinoin—Alitretinoin—ABCB1—colon cancer	0.000613	1	CrCbGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000606	0.00171	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000596	0.00169	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—colon cancer	0.000591	0.00167	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.00059	0.00167	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000586	0.00166	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000585	0.00165	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000581	0.00164	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000571	0.00161	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000566	0.0016	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—PPARG—colon cancer	0.000565	0.0016	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000564	0.00159	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	0.000562	0.00159	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.00056	0.00158	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000548	0.00155	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000543	0.00154	CbGpPWpGaD
Isotretinoin—Oedema—Irinotecan—colon cancer	0.000537	0.000895	CcSEcCtD
Isotretinoin—Anaphylactic shock—Irinotecan—colon cancer	0.000537	0.000895	CcSEcCtD
Isotretinoin—Chest pain—Fluorouracil—colon cancer	0.000537	0.000894	CcSEcCtD
Isotretinoin—Myalgia—Fluorouracil—colon cancer	0.000537	0.000894	CcSEcCtD
Isotretinoin—Infection—Irinotecan—colon cancer	0.000534	0.000889	CcSEcCtD
Isotretinoin—Hyperhidrosis—Vincristine—colon cancer	0.000533	0.000889	CcSEcCtD
Isotretinoin—Epistaxis—Capecitabine—colon cancer	0.000532	0.000886	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—DCC—colon cancer	0.000531	0.0015	CbGpPWpGaD
Isotretinoin—Discomfort—Fluorouracil—colon cancer	0.00053	0.000884	CcSEcCtD
Isotretinoin—Shock—Irinotecan—colon cancer	0.000529	0.000881	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000528	0.00149	CbGpPWpGaD
Isotretinoin—Nervous system disorder—Irinotecan—colon cancer	0.000527	0.000878	CcSEcCtD
Isotretinoin—Agranulocytosis—Capecitabine—colon cancer	0.000526	0.000877	CcSEcCtD
Isotretinoin—Thrombocytopenia—Irinotecan—colon cancer	0.000526	0.000876	CcSEcCtD
Isotretinoin—Anorexia—Vincristine—colon cancer	0.000526	0.000876	CcSEcCtD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.000522	0.00147	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000521	0.00147	CbGpPWpGaD
Isotretinoin—Irritability—Methotrexate—colon cancer	0.00052	0.000866	CcSEcCtD
Isotretinoin—Hyperhidrosis—Irinotecan—colon cancer	0.000519	0.000865	CcSEcCtD
Isotretinoin—Confusional state—Fluorouracil—colon cancer	0.000519	0.000864	CcSEcCtD
Isotretinoin—Mood swings—Methotrexate—colon cancer	0.000516	0.00086	CcSEcCtD
Isotretinoin—Hypotension—Vincristine—colon cancer	0.000515	0.000859	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000515	0.00145	CbGpPWpGaD
Isotretinoin—Oedema—Fluorouracil—colon cancer	0.000515	0.000857	CcSEcCtD
Isotretinoin—Anaphylactic shock—Fluorouracil—colon cancer	0.000515	0.000857	CcSEcCtD
Isotretinoin—Anorexia—Irinotecan—colon cancer	0.000512	0.000853	CcSEcCtD
Isotretinoin—Infection—Fluorouracil—colon cancer	0.000511	0.000852	CcSEcCtD
Isotretinoin—RARG—Gene Expression—HNF4A—colon cancer	0.00051	0.00144	CbGpPWpGaD
Isotretinoin—Haemoglobin—Capecitabine—colon cancer	0.000509	0.000847	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000507	0.00143	CbGpPWpGaD
Isotretinoin—Haemorrhage—Capecitabine—colon cancer	0.000506	0.000843	CcSEcCtD
Isotretinoin—Hepatitis—Capecitabine—colon cancer	0.000506	0.000843	CcSEcCtD
Isotretinoin—Nervous system disorder—Fluorouracil—colon cancer	0.000505	0.000841	CcSEcCtD
Isotretinoin—Thrombocytopenia—Fluorouracil—colon cancer	0.000504	0.000839	CcSEcCtD
Isotretinoin—Hypoaesthesia—Capecitabine—colon cancer	0.000504	0.000839	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000503	0.000837	CcSEcCtD
Isotretinoin—Pharyngitis—Capecitabine—colon cancer	0.000502	0.000837	CcSEcCtD
Isotretinoin—Tachycardia—Fluorouracil—colon cancer	0.000502	0.000837	CcSEcCtD
Isotretinoin—Hypotension—Irinotecan—colon cancer	0.000502	0.000836	CcSEcCtD
Isotretinoin—Urinary tract disorder—Capecitabine—colon cancer	0.0005	0.000833	CcSEcCtD
Isotretinoin—Insomnia—Vincristine—colon cancer	0.000499	0.000831	CcSEcCtD
Isotretinoin—Oedema peripheral—Capecitabine—colon cancer	0.000499	0.000831	CcSEcCtD
Isotretinoin—Urethral disorder—Capecitabine—colon cancer	0.000496	0.000827	CcSEcCtD
Isotretinoin—Paraesthesia—Vincristine—colon cancer	0.000495	0.000825	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000493	0.00139	CbGpPWpGaD
Isotretinoin—Anorexia—Fluorouracil—colon cancer	0.00049	0.000817	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00049	0.000817	CcSEcCtD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	0.000488	0.00138	CbGpPWpGaD
Isotretinoin—Visual impairment—Capecitabine—colon cancer	0.000488	0.000813	CcSEcCtD
Isotretinoin—Insomnia—Irinotecan—colon cancer	0.000486	0.00081	CcSEcCtD
Isotretinoin—Paraesthesia—Irinotecan—colon cancer	0.000482	0.000804	CcSEcCtD
Isotretinoin—Hypotension—Fluorouracil—colon cancer	0.000481	0.000801	CcSEcCtD
Isotretinoin—Decreased appetite—Vincristine—colon cancer	0.00048	0.000799	CcSEcCtD
Isotretinoin—Dyspnoea—Irinotecan—colon cancer	0.000479	0.000798	CcSEcCtD
Isotretinoin—Erythema multiforme—Capecitabine—colon cancer	0.000478	0.000797	CcSEcCtD
Isotretinoin—Somnolence—Irinotecan—colon cancer	0.000478	0.000796	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Vincristine—colon cancer	0.000476	0.000793	CcSEcCtD
Isotretinoin—Fatigue—Vincristine—colon cancer	0.000476	0.000792	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—HNF4A—colon cancer	0.000475	0.00134	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000474	0.00134	CbGpPWpGaD
Isotretinoin—Eye disorder—Capecitabine—colon cancer	0.000473	0.000788	CcSEcCtD
Isotretinoin—Dyspepsia—Irinotecan—colon cancer	0.000473	0.000788	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000472	0.00133	CbGpPWpGaD
Isotretinoin—Tinnitus—Capecitabine—colon cancer	0.000472	0.000786	CcSEcCtD
Isotretinoin—Pain—Vincristine—colon cancer	0.000472	0.000786	CcSEcCtD
Isotretinoin—Constipation—Vincristine—colon cancer	0.000472	0.000786	CcSEcCtD
Isotretinoin—Asthma—Methotrexate—colon cancer	0.000471	0.000784	CcSEcCtD
Isotretinoin—Flushing—Capecitabine—colon cancer	0.00047	0.000783	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000469	0.000781	CcSEcCtD
Isotretinoin—Decreased appetite—Irinotecan—colon cancer	0.000467	0.000778	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—HNF4A—colon cancer	0.000467	0.00132	CbGpPWpGaD
Isotretinoin—Insomnia—Fluorouracil—colon cancer	0.000465	0.000775	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000464	0.000773	CcSEcCtD
Isotretinoin—Fatigue—Irinotecan—colon cancer	0.000463	0.000772	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000463	0.00131	CbGpPWpGaD
Isotretinoin—Paraesthesia—Fluorouracil—colon cancer	0.000462	0.00077	CcSEcCtD
Isotretinoin—Pancreatitis—Methotrexate—colon cancer	0.000461	0.000769	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—PPARG—colon cancer	0.00046	0.0013	CbGpPWpGaD
Isotretinoin—Pain—Irinotecan—colon cancer	0.000459	0.000765	CcSEcCtD
Isotretinoin—Constipation—Irinotecan—colon cancer	0.000459	0.000765	CcSEcCtD
Isotretinoin—Angiopathy—Capecitabine—colon cancer	0.000459	0.000765	CcSEcCtD
Isotretinoin—Dyspnoea—Fluorouracil—colon cancer	0.000459	0.000764	CcSEcCtD
Isotretinoin—RARB—Gene Expression—HNF4A—colon cancer	0.000457	0.00129	CbGpPWpGaD
Isotretinoin—Somnolence—Fluorouracil—colon cancer	0.000457	0.000762	CcSEcCtD
Isotretinoin—Chills—Capecitabine—colon cancer	0.000454	0.000757	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000454	0.00128	CbGpPWpGaD
Isotretinoin—Dyspepsia—Fluorouracil—colon cancer	0.000453	0.000755	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000453	0.00128	CbGpPWpGaD
Isotretinoin—Arrhythmia—Capecitabine—colon cancer	0.000452	0.000753	CcSEcCtD
Isotretinoin—Abdominal discomfort—Methotrexate—colon cancer	0.000451	0.000752	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Vincristine—colon cancer	0.000451	0.000752	CcSEcCtD
Isotretinoin—Decreased appetite—Fluorouracil—colon cancer	0.000447	0.000745	CcSEcCtD
Isotretinoin—Alopecia—Capecitabine—colon cancer	0.000447	0.000745	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—HNF4A—colon cancer	0.000447	0.00126	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000444	0.00074	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000444	0.00125	CbGpPWpGaD
Isotretinoin—Mental disorder—Capecitabine—colon cancer	0.000443	0.000739	CcSEcCtD
Isotretinoin—Feeling abnormal—Irinotecan—colon cancer	0.000443	0.000738	CcSEcCtD
Isotretinoin—Erythema—Capecitabine—colon cancer	0.000441	0.000734	CcSEcCtD
Isotretinoin—Malnutrition—Capecitabine—colon cancer	0.000441	0.000734	CcSEcCtD
Isotretinoin—Dysuria—Methotrexate—colon cancer	0.00044	0.000733	CcSEcCtD
Isotretinoin—Neutropenia—Methotrexate—colon cancer	0.00044	0.000733	CcSEcCtD
Isotretinoin—Pain—Fluorouracil—colon cancer	0.00044	0.000733	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Irinotecan—colon cancer	0.000439	0.000732	CcSEcCtD
Isotretinoin—RARA—Gene Expression—HNF4A—colon cancer	0.000439	0.00124	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HNF4A—colon cancer	0.000439	0.00124	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000438	0.00124	CbGpPWpGaD
Isotretinoin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000437	0.000729	CcSEcCtD
Isotretinoin—Body temperature increased—Vincristine—colon cancer	0.000436	0.000727	CcSEcCtD
Isotretinoin—Abdominal pain—Vincristine—colon cancer	0.000436	0.000727	CcSEcCtD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000435	0.00123	CbGpPWpGaD
Isotretinoin—Flatulence—Capecitabine—colon cancer	0.000434	0.000723	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.00043	0.00121	CbGpPWpGaD
Isotretinoin—Photosensitivity reaction—Methotrexate—colon cancer	0.00043	0.000716	CcSEcCtD
Isotretinoin—Back pain—Capecitabine—colon cancer	0.000426	0.00071	CcSEcCtD
Isotretinoin—Abdominal pain—Irinotecan—colon cancer	0.000425	0.000708	CcSEcCtD
Isotretinoin—Body temperature increased—Irinotecan—colon cancer	0.000425	0.000708	CcSEcCtD
Isotretinoin—Feeling abnormal—Fluorouracil—colon cancer	0.000424	0.000706	CcSEcCtD
Isotretinoin—RXRA—PPARA activates gene expression—EP300—colon cancer	0.000422	0.00119	CbGpPWpGaD
Isotretinoin—Pneumonia—Methotrexate—colon cancer	0.000422	0.000703	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—PPARG—colon cancer	0.000421	0.00119	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CHST5—colon cancer	0.00042	0.00119	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ODC1—colon cancer	0.00042	0.00119	CbGpPWpGaD
Isotretinoin—Infestation—Methotrexate—colon cancer	0.00042	0.000699	CcSEcCtD
Isotretinoin—Infestation NOS—Methotrexate—colon cancer	0.00042	0.000699	CcSEcCtD
Isotretinoin—Drowsiness—Methotrexate—colon cancer	0.00042	0.000699	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000419	0.00119	CbGpPWpGaD
Isotretinoin—Depression—Methotrexate—colon cancer	0.000418	0.000697	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000416	0.000693	CcSEcCtD
Isotretinoin—Vision blurred—Capecitabine—colon cancer	0.000415	0.000692	CcSEcCtD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000413	0.00117	CbGpPWpGaD
Isotretinoin—Tremor—Capecitabine—colon cancer	0.000413	0.000688	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—PPARG—colon cancer	0.000413	0.00117	CbGpPWpGaD
Isotretinoin—Renal failure—Methotrexate—colon cancer	0.000413	0.000687	CcSEcCtD
Isotretinoin—Stomatitis—Methotrexate—colon cancer	0.000409	0.000682	CcSEcCtD
Isotretinoin—Ill-defined disorder—Capecitabine—colon cancer	0.000409	0.000681	CcSEcCtD
Isotretinoin—Urticaria—Fluorouracil—colon cancer	0.000409	0.000681	CcSEcCtD
Isotretinoin—Conjunctivitis—Methotrexate—colon cancer	0.000408	0.00068	CcSEcCtD
Isotretinoin—Anaemia—Capecitabine—colon cancer	0.000407	0.000678	CcSEcCtD
Isotretinoin—Body temperature increased—Fluorouracil—colon cancer	0.000407	0.000678	CcSEcCtD
Isotretinoin—Hypersensitivity—Vincristine—colon cancer	0.000406	0.000677	CcSEcCtD
Isotretinoin—Sweating—Methotrexate—colon cancer	0.000402	0.00067	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000402	0.00114	CbGpPWpGaD
Isotretinoin—Haematuria—Methotrexate—colon cancer	0.0004	0.000667	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—CTNNB1—colon cancer	0.000397	0.00112	CbGpPWpGaD
Isotretinoin—Malaise—Capecitabine—colon cancer	0.000397	0.000662	CcSEcCtD
Isotretinoin—Epistaxis—Methotrexate—colon cancer	0.000396	0.00066	CcSEcCtD
Isotretinoin—Hypersensitivity—Irinotecan—colon cancer	0.000396	0.000659	CcSEcCtD
Isotretinoin—Asthenia—Vincristine—colon cancer	0.000396	0.000659	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—PPARG—colon cancer	0.000396	0.00112	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—PPARG—colon cancer	0.000396	0.00112	CbGpPWpGaD
Isotretinoin—Syncope—Capecitabine—colon cancer	0.000395	0.000658	CcSEcCtD
Isotretinoin—Agranulocytosis—Methotrexate—colon cancer	0.000392	0.000653	CcSEcCtD
Isotretinoin—Palpitations—Capecitabine—colon cancer	0.000389	0.000649	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000389	0.0011	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CDKN1A—colon cancer	0.000388	0.0011	CbGpPWpGaD
Isotretinoin—Loss of consciousness—Capecitabine—colon cancer	0.000387	0.000645	CcSEcCtD
Isotretinoin—Asthenia—Irinotecan—colon cancer	0.000385	0.000642	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000385	0.00109	CbGpPWpGaD
Isotretinoin—Cough—Capecitabine—colon cancer	0.000384	0.000641	CcSEcCtD
Isotretinoin—Hypertension—Capecitabine—colon cancer	0.00038	0.000634	CcSEcCtD
Isotretinoin—Hypersensitivity—Fluorouracil—colon cancer	0.000379	0.000632	CcSEcCtD
Isotretinoin—Haemoglobin—Methotrexate—colon cancer	0.000379	0.000631	CcSEcCtD
Isotretinoin—Diarrhoea—Vincristine—colon cancer	0.000377	0.000629	CcSEcCtD
Isotretinoin—Haemorrhage—Methotrexate—colon cancer	0.000377	0.000628	CcSEcCtD
Isotretinoin—Hepatitis—Methotrexate—colon cancer	0.000377	0.000628	CcSEcCtD
Isotretinoin—Myalgia—Capecitabine—colon cancer	0.000375	0.000625	CcSEcCtD
Isotretinoin—Chest pain—Capecitabine—colon cancer	0.000375	0.000625	CcSEcCtD
Isotretinoin—Arthralgia—Capecitabine—colon cancer	0.000375	0.000625	CcSEcCtD
Isotretinoin—Pharyngitis—Methotrexate—colon cancer	0.000374	0.000623	CcSEcCtD
Isotretinoin—Anxiety—Capecitabine—colon cancer	0.000374	0.000623	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000373	0.00105	CbGpPWpGaD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000372	0.000621	CcSEcCtD
Isotretinoin—Urinary tract disorder—Methotrexate—colon cancer	0.000372	0.00062	CcSEcCtD
Isotretinoin—Discomfort—Capecitabine—colon cancer	0.000371	0.000617	CcSEcCtD
Isotretinoin—Urethral disorder—Methotrexate—colon cancer	0.000369	0.000615	CcSEcCtD
Isotretinoin—Diarrhoea—Irinotecan—colon cancer	0.000368	0.000612	CcSEcCtD
Isotretinoin—Dry mouth—Capecitabine—colon cancer	0.000367	0.000611	CcSEcCtD
Isotretinoin—Dizziness—Vincristine—colon cancer	0.000365	0.000608	CcSEcCtD
Isotretinoin—Pruritus—Fluorouracil—colon cancer	0.000364	0.000607	CcSEcCtD
Isotretinoin—Visual impairment—Methotrexate—colon cancer	0.000363	0.000605	CcSEcCtD
Isotretinoin—Confusional state—Capecitabine—colon cancer	0.000363	0.000604	CcSEcCtD
Isotretinoin—Oedema—Capecitabine—colon cancer	0.00036	0.000599	CcSEcCtD
Isotretinoin—Infection—Capecitabine—colon cancer	0.000357	0.000595	CcSEcCtD
Isotretinoin—Erythema multiforme—Methotrexate—colon cancer	0.000356	0.000593	CcSEcCtD
Isotretinoin—Dizziness—Irinotecan—colon cancer	0.000355	0.000592	CcSEcCtD
Isotretinoin—Shock—Capecitabine—colon cancer	0.000354	0.000589	CcSEcCtD
Isotretinoin—Nervous system disorder—Capecitabine—colon cancer	0.000353	0.000587	CcSEcCtD
Isotretinoin—Eye disorder—Methotrexate—colon cancer	0.000352	0.000587	CcSEcCtD
Isotretinoin—Diarrhoea—Fluorouracil—colon cancer	0.000352	0.000587	CcSEcCtD
Isotretinoin—Thrombocytopenia—Capecitabine—colon cancer	0.000352	0.000587	CcSEcCtD
Isotretinoin—Tinnitus—Methotrexate—colon cancer	0.000351	0.000585	CcSEcCtD
Isotretinoin—Tachycardia—Capecitabine—colon cancer	0.000351	0.000585	CcSEcCtD
Isotretinoin—Vomiting—Vincristine—colon cancer	0.000351	0.000584	CcSEcCtD
Isotretinoin—Skin disorder—Capecitabine—colon cancer	0.000349	0.000582	CcSEcCtD
Isotretinoin—Rash—Vincristine—colon cancer	0.000348	0.000579	CcSEcCtD
Isotretinoin—Hyperhidrosis—Capecitabine—colon cancer	0.000348	0.000579	CcSEcCtD
Isotretinoin—Dermatitis—Vincristine—colon cancer	0.000347	0.000579	CcSEcCtD
Isotretinoin—Headache—Vincristine—colon cancer	0.000346	0.000576	CcSEcCtD
Isotretinoin—Anorexia—Capecitabine—colon cancer	0.000343	0.000571	CcSEcCtD
Isotretinoin—Angiopathy—Methotrexate—colon cancer	0.000342	0.00057	CcSEcCtD
Isotretinoin—Vomiting—Irinotecan—colon cancer	0.000342	0.000569	CcSEcCtD
Isotretinoin—Dizziness—Fluorouracil—colon cancer	0.00034	0.000567	CcSEcCtD
Isotretinoin—Rash—Irinotecan—colon cancer	0.000339	0.000564	CcSEcCtD
Isotretinoin—Dermatitis—Irinotecan—colon cancer	0.000338	0.000564	CcSEcCtD
Isotretinoin—Chills—Methotrexate—colon cancer	0.000338	0.000563	CcSEcCtD
Isotretinoin—Headache—Irinotecan—colon cancer	0.000337	0.000561	CcSEcCtD
Isotretinoin—Hypotension—Capecitabine—colon cancer	0.000336	0.00056	CcSEcCtD
Isotretinoin—Alopecia—Methotrexate—colon cancer	0.000333	0.000555	CcSEcCtD
Isotretinoin—Mental disorder—Methotrexate—colon cancer	0.00033	0.00055	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000328	0.000928	CbGpPWpGaD
Isotretinoin—Erythema—Methotrexate—colon cancer	0.000328	0.000546	CcSEcCtD
Isotretinoin—Malnutrition—Methotrexate—colon cancer	0.000328	0.000546	CcSEcCtD
Isotretinoin—Nausea—Vincristine—colon cancer	0.000328	0.000546	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000328	0.000546	CcSEcCtD
Isotretinoin—Vomiting—Fluorouracil—colon cancer	0.000327	0.000545	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000326	0.000922	CbGpPWpGaD
Isotretinoin—Insomnia—Capecitabine—colon cancer	0.000325	0.000542	CcSEcCtD
Isotretinoin—Rash—Fluorouracil—colon cancer	0.000324	0.000541	CcSEcCtD
Isotretinoin—Dermatitis—Fluorouracil—colon cancer	0.000324	0.00054	CcSEcCtD
Isotretinoin—Paraesthesia—Capecitabine—colon cancer	0.000323	0.000538	CcSEcCtD
Isotretinoin—Headache—Fluorouracil—colon cancer	0.000322	0.000537	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—TGFB1—colon cancer	0.000321	0.000907	CbGpPWpGaD
Isotretinoin—Dyspnoea—Capecitabine—colon cancer	0.000321	0.000534	CcSEcCtD
Isotretinoin—Nausea—Irinotecan—colon cancer	0.000319	0.000532	CcSEcCtD
Isotretinoin—Back pain—Methotrexate—colon cancer	0.000317	0.000529	CcSEcCtD
Isotretinoin—Dyspepsia—Capecitabine—colon cancer	0.000316	0.000527	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000315	0.00089	CbGpPWpGaD
Isotretinoin—Decreased appetite—Capecitabine—colon cancer	0.000313	0.000521	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Capecitabine—colon cancer	0.00031	0.000517	CcSEcCtD
Isotretinoin—Fatigue—Capecitabine—colon cancer	0.00031	0.000516	CcSEcCtD
Isotretinoin—Vision blurred—Methotrexate—colon cancer	0.000309	0.000515	CcSEcCtD
Isotretinoin—Constipation—Capecitabine—colon cancer	0.000307	0.000512	CcSEcCtD
Isotretinoin—Pain—Capecitabine—colon cancer	0.000307	0.000512	CcSEcCtD
Isotretinoin—Nausea—Fluorouracil—colon cancer	0.000306	0.000509	CcSEcCtD
Isotretinoin—Ill-defined disorder—Methotrexate—colon cancer	0.000304	0.000507	CcSEcCtD
Isotretinoin—Anaemia—Methotrexate—colon cancer	0.000303	0.000505	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000303	0.000856	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Capecitabine—colon cancer	0.000296	0.000494	CcSEcCtD
Isotretinoin—Malaise—Methotrexate—colon cancer	0.000296	0.000493	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000295	0.000833	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Capecitabine—colon cancer	0.000294	0.00049	CcSEcCtD
Isotretinoin—RXRA—NRF2 pathway—TGFB1—colon cancer	0.000293	0.000827	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000292	0.000825	CbGpPWpGaD
Isotretinoin—Cough—Methotrexate—colon cancer	0.000286	0.000477	CcSEcCtD
Isotretinoin—Urticaria—Capecitabine—colon cancer	0.000286	0.000476	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000285	0.000806	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000285	0.000804	CbGpPWpGaD
Isotretinoin—Abdominal pain—Capecitabine—colon cancer	0.000284	0.000474	CcSEcCtD
Isotretinoin—Body temperature increased—Capecitabine—colon cancer	0.000284	0.000474	CcSEcCtD
Isotretinoin—Convulsion—Methotrexate—colon cancer	0.000284	0.000473	CcSEcCtD
Isotretinoin—Chest pain—Methotrexate—colon cancer	0.000279	0.000465	CcSEcCtD
Isotretinoin—Myalgia—Methotrexate—colon cancer	0.000279	0.000465	CcSEcCtD
Isotretinoin—Arthralgia—Methotrexate—colon cancer	0.000279	0.000465	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000277	0.000462	CcSEcCtD
Isotretinoin—Discomfort—Methotrexate—colon cancer	0.000276	0.00046	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000272	0.000767	CbGpPWpGaD
Isotretinoin—Confusional state—Methotrexate—colon cancer	0.00027	0.00045	CcSEcCtD
Isotretinoin—Anaphylactic shock—Methotrexate—colon cancer	0.000268	0.000446	CcSEcCtD
Isotretinoin—Infection—Methotrexate—colon cancer	0.000266	0.000443	CcSEcCtD
Isotretinoin—Hypersensitivity—Capecitabine—colon cancer	0.000265	0.000441	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000264	0.000746	CbGpPWpGaD
Isotretinoin—Nervous system disorder—Methotrexate—colon cancer	0.000262	0.000437	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—colon cancer	0.000262	0.000741	CbGpPWpGaD
Isotretinoin—Thrombocytopenia—Methotrexate—colon cancer	0.000262	0.000437	CcSEcCtD
Isotretinoin—Skin disorder—Methotrexate—colon cancer	0.00026	0.000433	CcSEcCtD
Isotretinoin—Hyperhidrosis—Methotrexate—colon cancer	0.000259	0.000431	CcSEcCtD
Isotretinoin—Asthenia—Capecitabine—colon cancer	0.000258	0.00043	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000257	0.000727	CbGpPWpGaD
Isotretinoin—Anorexia—Methotrexate—colon cancer	0.000255	0.000425	CcSEcCtD
Isotretinoin—Pruritus—Capecitabine—colon cancer	0.000254	0.000424	CcSEcCtD
Isotretinoin—Hypotension—Methotrexate—colon cancer	0.00025	0.000417	CcSEcCtD
Isotretinoin—Diarrhoea—Capecitabine—colon cancer	0.000246	0.00041	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000244	0.000406	CcSEcCtD
Isotretinoin—Insomnia—Methotrexate—colon cancer	0.000242	0.000403	CcSEcCtD
Isotretinoin—Paraesthesia—Methotrexate—colon cancer	0.00024	0.0004	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—colon cancer	0.00024	0.000678	CbGpPWpGaD
Isotretinoin—Dyspnoea—Methotrexate—colon cancer	0.000239	0.000398	CcSEcCtD
Isotretinoin—Somnolence—Methotrexate—colon cancer	0.000238	0.000396	CcSEcCtD
Isotretinoin—Dizziness—Capecitabine—colon cancer	0.000238	0.000396	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000237	0.000669	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000237	0.000669	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000236	0.000667	CbGpPWpGaD
Isotretinoin—Dyspepsia—Methotrexate—colon cancer	0.000236	0.000393	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—colon cancer	0.000235	0.000665	CbGpPWpGaD
Isotretinoin—Decreased appetite—Methotrexate—colon cancer	0.000233	0.000388	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000231	0.000654	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000231	0.000385	CcSEcCtD
Isotretinoin—Fatigue—Methotrexate—colon cancer	0.000231	0.000384	CcSEcCtD
Isotretinoin—Pain—Methotrexate—colon cancer	0.000229	0.000381	CcSEcCtD
Isotretinoin—Vomiting—Capecitabine—colon cancer	0.000229	0.000381	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—HNF4A—colon cancer	0.000229	0.000646	CbGpPWpGaD
Isotretinoin—Rash—Capecitabine—colon cancer	0.000227	0.000378	CcSEcCtD
Isotretinoin—Dermatitis—Capecitabine—colon cancer	0.000226	0.000377	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—colon cancer	0.000226	0.000637	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—colon cancer	0.000226	0.000637	CbGpPWpGaD
Isotretinoin—Headache—Capecitabine—colon cancer	0.000225	0.000375	CcSEcCtD
Isotretinoin—RARG—Gene Expression—PPARG—colon cancer	0.000221	0.000626	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Methotrexate—colon cancer	0.000221	0.000367	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Methotrexate—colon cancer	0.000219	0.000365	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000219	0.000618	CbGpPWpGaD
Isotretinoin—Nausea—Capecitabine—colon cancer	0.000214	0.000356	CcSEcCtD
Isotretinoin—Urticaria—Methotrexate—colon cancer	0.000213	0.000354	CcSEcCtD
Isotretinoin—Body temperature increased—Methotrexate—colon cancer	0.000212	0.000353	CcSEcCtD
Isotretinoin—Abdominal pain—Methotrexate—colon cancer	0.000212	0.000353	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—PPARG—colon cancer	0.000206	0.000583	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PPARG—colon cancer	0.000203	0.000572	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000201	0.000568	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PPARG—colon cancer	0.000199	0.000561	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Methotrexate—colon cancer	0.000197	0.000329	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000194	0.000549	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PPARG—colon cancer	0.000194	0.000548	CbGpPWpGaD
Isotretinoin—Asthenia—Methotrexate—colon cancer	0.000192	0.00032	CcSEcCtD
Isotretinoin—RARA—Gene Expression—PPARG—colon cancer	0.00019	0.000538	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PPARG—colon cancer	0.00019	0.000538	CbGpPWpGaD
Isotretinoin—Pruritus—Methotrexate—colon cancer	0.000189	0.000316	CcSEcCtD
Isotretinoin—Diarrhoea—Methotrexate—colon cancer	0.000183	0.000305	CcSEcCtD
Isotretinoin—Dizziness—Methotrexate—colon cancer	0.000177	0.000295	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000173	0.00049	CbGpPWpGaD
Isotretinoin—Vomiting—Methotrexate—colon cancer	0.00017	0.000284	CcSEcCtD
Isotretinoin—Rash—Methotrexate—colon cancer	0.000169	0.000281	CcSEcCtD
Isotretinoin—Dermatitis—Methotrexate—colon cancer	0.000169	0.000281	CcSEcCtD
Isotretinoin—Headache—Methotrexate—colon cancer	0.000168	0.000279	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000164	0.000464	CbGpPWpGaD
Isotretinoin—Nausea—Methotrexate—colon cancer	0.000159	0.000265	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—CTNNB1—colon cancer	0.000137	0.000386	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000136	0.000385	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EP300—colon cancer	0.000127	0.000359	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—colon cancer	0.000126	0.000357	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SRC—colon cancer	0.000123	0.000349	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—colon cancer	0.00012	0.00034	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NRAS—colon cancer	0.000119	0.000336	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—colon cancer	0.000118	0.000332	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—colon cancer	0.000115	0.000326	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000113	0.00032	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—colon cancer	0.000113	0.00032	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCB1—colon cancer	0.000111	0.000313	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TGFB1—colon cancer	0.00011	0.000312	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TYMS—colon cancer	0.000109	0.000308	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—colon cancer	0.000109	0.000307	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—colon cancer	0.000109	0.000307	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—colon cancer	0.000108	0.000306	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KRAS—colon cancer	0.000102	0.000289	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PPARG—colon cancer	9.93e-05	0.00028	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AKT1—colon cancer	8.76e-05	0.000247	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HRAS—colon cancer	8.69e-05	0.000246	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.39e-05	0.000237	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AKT1—colon cancer	8.01e-05	0.000226	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AKT1—colon cancer	7.85e-05	0.000222	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PPARG—colon cancer	7.72e-05	0.000218	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—AKT1—colon cancer	7.67e-05	0.000217	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AKT1—colon cancer	7.53e-05	0.000213	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AKT1—colon cancer	7.53e-05	0.000213	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—colon cancer	6.07e-05	0.000172	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—colon cancer	5.66e-05	0.00016	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—EP300—colon cancer	5.05e-05	0.000143	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AKT1—colon cancer	3.92e-05	0.000111	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—colon cancer	3.74e-05	0.000106	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKT1—colon cancer	3.05e-05	8.62e-05	CbGpPWpGaD
